norml08 - Page 23
Page 23
Previous ,
Next ,
Original Image
Return to Index
'!/_:::_: A fifth group of drugs was accepted for research use
only, not for use in treatment of pa_zients. 21 U.S.C.
355(i) (so-called 'WIND or approved investigational new
drugs_)o
Drugs intended for medical use and shipped interstate
are subject to Federal seizure under the FDCA if they do not
fit within one of the above accepted sets or groupings. It
seems fair to say that seizable drugs were rejected by
Congress for medical uses.
In enacting the Controlled Substances Act in 1970,
could Congress have intended to create a totally new Federal
standard for determining whether drugs have accepted medical
uses? Or did Congress intend to rely on standards it had
developed over the prior 64 years under the FDCA? There is
nothing in the Controlled Substances Acts its legislative
history, or its purposes that would indicate Congress
intended to depart radically from existing Federal law.
Indeed, it seems likely that the core standards
developed under the FDCA represent a long-term consensus of
expert medical and scientific opinion concerning when a drug
should be accepted by anyone as safe and effective for
medical use.
Fortunately, there is a way to corroborate what
Congress intended. Congress did more than just announce
criteria for scheduling drugs of abuse under the Controlled
Substances Act; Congress applied those criteria to an
:![:
23
Previous ,
Next ,
Return to Index